Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$261M |
| 2 |
Alibaba
BABA
|
+$233M |
| 3 |
Truist Financial
TFC
|
+$191M |
| 4 |
Microsoft
MSFT
|
+$160M |
| 5 |
Amazon
AMZN
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$415M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$186M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$73.8M |
| 4 |
Oracle
ORCL
|
+$25.8M |
| 5 |
CBLK
Carbon Black, Inc. Common Stock
CBLK
|
+$23.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.21% |
| 2 | Financials | 15.12% |
| 3 | Healthcare | 12.68% |
| 4 | Consumer Discretionary | 10.28% |
| 5 | Communication Services | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Beazer Homes USA
BZH
$936M
| $83K | ﹤0.01% |
5,873
| – | – |
|
|
JE
2652
DELISTED
Just Energy Group Inc
JE
| $83K | ﹤0.01% |
1,488
| – | – |
|
2653
Bloom Energy
BE
$68.9B
| $82K | ﹤0.01% |
11,013
| – | – |
|
2654
Bank First Corp
BFC
$1.73B
| $82K | ﹤0.01% |
1,179
+211
| +22% | +$14.4K |
|
2655
Endava
DAVA
$157M
| $82K | ﹤0.01% |
1,763
+1,389
| +371% | +$59.9K |
|
2656
Dorian LPG
LPG
$1.87B
| $82K | ﹤0.01% |
5,274
+222
| +4% | +$2.92K |
|
|
SY
2657
So-Young International
SY
$203M
| $82K | ﹤0.01% |
+6,699
| New | +$74.2K |
|
|
XOG
2658
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
| $82K | ﹤0.01% |
38,628
| – | – |
|
|
TLRA
2659
DELISTED
Telaria, Inc.
TLRA
| $82K | ﹤0.01% |
9,337
+1,652
| +21% | +$12.9K |
|
|
AGS
2660
DELISTED
PlayAGS
AGS
| $81K | ﹤0.01% |
6,672
+1,082
| +19% | +$12.3K |
|
|
CPRX
2661
DELISTED
Catalyst Pharmaceutical
CPRX
| $81K | ﹤0.01% |
21,557
-1,371
| -6% | -$6.41K |
|
2662
The RealReal
REAL
$1.5B
| $81K | ﹤0.01% |
4,332
+1,415
| +49% | +$27.1K |
|
|
RUBY
2663
DELISTED
Rubius Therapeutics, Inc
RUBY
| $81K | ﹤0.01% |
8,539
+1,317
| +18% | +$12.7K |
|
|
HONE
2664
DELISTED
HarborOne Bancorp
HONE
| $80K | ﹤0.01% |
7,310
+477
| +7% | +$5K |
|
|
PWOD
2665
DELISTED
Penns Woods Bancorp
PWOD
| $80K | ﹤0.01% |
2,239
-1
| -0% | -$32 |
|
|
EVFM
2666
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $80K | ﹤0.01% |
859
+702
| +447% | +$59.2K |
|
2667
Health Catalyst
HCAT
$171M
| $79K | ﹤0.01% |
2,284
+926
| +68% | +$30.7K |
|
2668
Sterling Infrastructure
STRL
$16.9B
| $79K | ﹤0.01% |
5,666
+1,246
| +28% | +$18.8K |
|
2669
Voyager Therapeutics
VYGR
$187M
| $79K | ﹤0.01% |
5,662
+915
| +19% | +$13.3K |
|
|
VSLR
2670
DELISTED
VIVINT SOLAR, INC.
VSLR
| $79K | ﹤0.01% |
10,916
+1,620
| +17% | +$11.4K |
|
|
BHR
2671
Braemar Hotels & Resorts
BHR
$143M
| $78K | ﹤0.01% |
8,719
-87
| -1% | -$814 |
|
2672
Greif Class B
GEF.B
$4.24B
| $78K | ﹤0.01% |
1,513
+622
| +70% | +$30.9K |
|
2673
Global Industrial
GIC
$1.47B
| $78K | ﹤0.01% |
3,115
+372
| +14% | +$8.68K |
|
2674
Puma Biotechnology
PBYI
$409M
| $78K | ﹤0.01% |
8,945
+1,172
| +15% | +$9.7K |
|
2675
Rigel Pharmaceuticals
RIGL
$738M
| $78K | ﹤0.01% |
3,614
+595
| +20% | +$12.3K |
|
Similar funds
Legal & General Group's Q4 2019 Portfolio in Review
As of Q4 2019, Legal & General Group held 3,425 positions worth $210B, up 11% from $190B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 3.9%. Legal & General Group opened 77 new positions and exited 57, leaving the 3,425-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
- Legal & General Group's largest Q4 2019 buy was iShares MSCI Emerging Markets ETF: 425,000 shares worth $19.1M.
- Legal & General Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $261M increase.
- Legal & General Group's biggest Q4 2019 reduction was Oracle, cutting an estimated $25.8M.
- Legal & General Group fully exited Celgene Corp in Q4 2019, selling an estimated $415M.
- Legal & General Group's ten largest holdings make up 18% of its $210B portfolio in Q4 2019.
- Legal & General Group opened 77 new positions and closed 57 in Q4 2019.
- Legal & General Group's portfolio value rose 11% quarter-over-quarter to $210B.
Based on Legal & General Group's 13F filing for Q4 2019, filed 13 Feb 2020.